Enovis Corporation LSE:0I1B.L

Founder-led company

Enovis stock price today

$33.37
-10.42
-23.8%
Financial Health
0
1
2
3
4
5
6
7
8
9

Enovis stock price monthly change

-4.28%
month

Enovis stock price quarterly change

-4.28%
quarter

Enovis stock price yearly change

-22.55%
year

Enovis key metrics

Market Cap
2.44B
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-1.49
Revenue
1.81B
EBITDA
129.57M
Income
-81.90M
Revenue Q/Q
27.11%
Revenue Y/Y
14.02%
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
7.13%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Enovis stock price history

Enovis stock forecast

Enovis financial statements

Enovis Corporation (LSE:0I1B.L): Profit margin
Jun 2023 428.50M -9.99M -2.33%
Sep 2023 417.52M -2.88M -0.69%
Dec 2023 455.02M 2.96M 0.65%
Mar 2024 516.26M -71.99M -13.95%
Enovis Corporation (LSE:0I1B.L): Analyst Estimates
Sep 2025 552.74M 39.58M 7.16%
Sep 2025 555.38M 39.54M 7.12%
Dec 2025 610.04M 55.62M 9.12%
Dec 2025 609.72M 54.42M 8.93%
  • Analysts Price target

  • Financials & Ratios estimates

Enovis Corporation (LSE:0I1B.L): Debt to assets
Jun 2023 4443553000 992.79M 22.34%
Sep 2023 4400917000 959.18M 21.8%
Dec 2023 4509334000 1.08B 24.14%
Mar 2024 5478681000 2.16B 39.57%
Enovis Corporation (LSE:0I1B.L): Cash Flow
Jun 2023 28.10M -131.60M 114.21M
Sep 2023 31.01M -17.10M -13.70M
Dec 2023 68.41M -59.37M 2.78M
Mar 2024 -36.15M -797.84M 864.54M

Enovis alternative data

Enovis Corporation (LSE:0I1B.L): Employee count
Aug 2023 16,200
Sep 2023 16,200
Oct 2023 16,200
Nov 2023 16,200
Dec 2023 16,200
Jan 2024 16,200
Feb 2024 16,200
Mar 2024 16,200
Apr 2024 16,200
May 2024 16,200
Jun 2024 6,550
Jul 2024 6,550

Enovis other data

Insider Compensation
Mr. Matthew L. Trerotola (1967) Pres, Chief Executive Officer & Director $2,980,000
Mr. Brady R. Shirley (1966) Chief Executive Officer of DJO & Executive Vice President
$1,440,000
Mr. Shyam Kambeyanda (1971) Executive Vice President and Chief Executive Officer & Pres of ESAB $1,260,000
Mr. Christopher M. Hix (1962) Executive Vice President of Fin. & Chief Financial Officer $1,150,000
Mr. Daniel A. Pryor (1968) Executive Vice President of Strategy & Bus. Devel. $1,130,000
Mr. Mitchell P. Rales (1957) Co-Founder & Chairman $1
Mr. Steven L. Breitzka Interim Senior Vice President of Global Operations & Americas
Ms. Patricia A. Lang Senior Vice President & Chief HR Officer
Mr. Bradley J. Tandy Senior Vice President, Gen. Counsel & Sec.
Mr. Terry Ross Vice President of Investor Relations, Strategy & Bus. Devel.
  • What's the price of Enovis stock today?

    One share of Enovis stock can currently be purchased for approximately $33.37.

  • When is Enovis's next earnings date?

    Unfortunately, Enovis's (0I1B.L) next earnings date is currently unknown.

  • Does Enovis pay dividends?

    No, Enovis does not pay dividends.

  • How much money does Enovis make?

    Enovis has a market capitalization of 2.44B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.22% to 1.71B US dollars.

  • What is Enovis's stock symbol?

    Enovis Corporation is traded on the LSE under the ticker symbol "0I1B.L".

  • What is Enovis's primary industry?

    Company operates in the Industrials sector and Industrial - Capital Goods industry.

  • How do i buy shares of Enovis?

    Shares of Enovis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Enovis's key executives?

    Enovis's management team includes the following people:

    • Mr. Matthew L. Trerotola Pres, Chief Executive Officer & Director(age: 58, pay: $2,980,000)
    • Mr. Brady R. Shirley Chief Executive Officer of DJO & Executive Vice President(age: 59, pay: $1,440,000)
    • Mr. Shyam Kambeyanda Executive Vice President and Chief Executive Officer & Pres of ESAB(age: 54, pay: $1,260,000)
    • Mr. Christopher M. Hix Executive Vice President of Fin. & Chief Financial Officer(age: 63, pay: $1,150,000)
    • Mr. Daniel A. Pryor Executive Vice President of Strategy & Bus. Devel.(age: 57, pay: $1,130,000)
    • Mr. Mitchell P. Rales Co-Founder & Chairman(age: 68, pay: $1)
    • Mr. Steven L. Breitzka Interim Senior Vice President of Global Operations & Americas
    • Ms. Patricia A. Lang Senior Vice President & Chief HR Officer
    • Mr. Bradley J. Tandy Senior Vice President, Gen. Counsel & Sec.
    • Mr. Terry Ross Vice President of Investor Relations, Strategy & Bus. Devel.
  • Is Enovis founder-led company?

    Yes, Enovis is a company led by its founder Mr. Mitchell P. Rales.

  • How many employees does Enovis have?

    As Jul 2024, Enovis employs 6,550 workers, which is 60% less then previous quarter.

  • When Enovis went public?

    Enovis Corporation is publicly traded company for more then 17 years since IPO on 8 May 2008.

  • What is Enovis's official website?

    The official website for Enovis is enovis.com.

  • Where are Enovis's headquarters?

    Enovis is headquartered at 2711 Centerville Road, Wilmington, DE.

  • How can i contact Enovis?

    Enovis's mailing address is 2711 Centerville Road, Wilmington, DE and company can be reached via phone at +30 22529190.

Enovis company profile:

Enovis Corporation

enovis.com
Exchange:

LSE

Full time employees:

6,550

Industry:

Industrial - Capital Goods

Sector:

Industrials

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

2711 Centerville Road
Wilmington, DE 19808

:
ISIN: US1940145022
: